Amy Beth Vanduyn Sells 685 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 685 shares of Phreesia stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $15,659.10. Following the sale, the senior vice president now directly owns 119,010 shares of the company’s stock, valued at approximately $2,720,568.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Monday, April 8th, Amy Beth Vanduyn sold 3,354 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $75,867.48.

Phreesia Stock Performance

PHR opened at $23.16 on Thursday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. The stock’s 50 day moving average price is $24.49 and its two-hundred day moving average price is $21.25. The firm has a market capitalization of $1.31 billion, a P/E ratio of -9.19 and a beta of 0.92. Phreesia, Inc. has a 12-month low of $12.05 and a 12-month high of $34.98.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. During the same period in the prior year, the business earned ($0.72) earnings per share. Phreesia’s revenue for the quarter was up 24.0% compared to the same quarter last year. On average, equities analysts forecast that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on PHR shares. JMP Securities raised their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research report on Thursday, March 21st. Raymond James restated an “outperform” rating and set a $30.00 price target (up previously from $25.00) on shares of Phreesia in a report on Friday, March 15th. DA Davidson reiterated a “neutral” rating and issued a $32.00 price objective on shares of Phreesia in a report on Friday, March 15th. Barclays assumed coverage on Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 target price on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday, March 15th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Acadian Asset Management LLC bought a new stake in shares of Phreesia in the first quarter valued at about $43,000. Captrust Financial Advisors raised its holdings in Phreesia by 154.6% in the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after acquiring an additional 866 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after acquiring an additional 1,411 shares during the period. State of Wyoming grew its holdings in shares of Phreesia by 34.6% during the 2nd quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after purchasing an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Phreesia by 85.4% during the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock valued at $80,000 after purchasing an additional 1,445 shares during the period. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.